Please provide your email address to receive an email when new articles are posted on . Transarterial chemoembolization plus vitamin K prolonged progression-free survival compared with TACE alone (262 ...
To earn CME related to this news article, click here. December 24, 2008 — Chemoembolization is a minimally invasive therapy option for palliative treatment of liver metastases in patients with ...
NEW YORK (Medscape Wire) May 22 -- Chemoembolization should be the standard approach in selected patients with unresectable hepatocellular carcinoma, based on improved survival in a randomized trial ...
Please provide your email address to receive an email when new articles are posted on . Hepatocellular carcinoma accounts for approximately 90% of all primary liver cancer cases, according to Zhen-Wei ...
Transarterial Chemoembolization and Immunotherapy: Another Good Marriage? The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...
Hepatocellular carcinoma (HCC) poses a substantial health burden globally, with liver cancer being the fourth most common cause of cancer-related mortality worldwide. In China, where the incidence of ...
Regional chemotherapy via a tumour-feeding artery achieves higher drug exposure at the target site than with corresponding systemic exposure and, therefore, has the possibility of generating higher ...
TOKYO, Jul 29, 2025 - (JCN Newswire) - - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that its in-house discovered tyrosine kinase inhibitor, "LENVIMA(R)" (generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results